Envista Holdings Corp (NVST) is a Medical - Equipment & Services company in the Healthcare sector, currently trading at $27.38. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of NVST = $19.72 (-28% from the current price, the stock appears overvalued). Analyst consensus target is NVST = $27 (-0.6% upside).
Valuation: NVST trades at a trailing Price-to-Earnings (P/E) of 92.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 8.7.
Financials: revenue is $2.7B, +2%/yr average growth. Net income is $47M, growing at -351.1%/yr. Net profit margin is 1.7% (thin). Gross margin is 55% (-2.4 pp trend).
Balance sheet: total debt is $1.7B against $3.1B equity (Debt-to-Equity (D/E) ratio 0.55, moderate). Current ratio is 2.38 (strong liquidity). Debt-to-assets is 30.1%. Total assets: $5.7B.
Analyst outlook: 7 / 19 analysts rate NVST as buy (37%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 30/100 (Fail), Past 50/100 (Partial), Health 67/100 (Partial), Moat 65/100 (Partial), Future 26/100 (Fail), Income 30/100 (Fail).
